Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Eun Wie Cho"'
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mese
Externí odkaz:
https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68
Autor:
Chang-Kyu Heo, Won-Hee Lim, Ki-Beom Moon, Jihyun Yang, Sang Jick Kim, Hyun-Soon Kim, Doo-Jin Kim, Eun-Wie Cho
Publikováno v:
Vaccines, Vol 12, Iss 6, p 676 (2024)
Approved COVID-19 vaccines primarily induce neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the emergence of variants of concern with RBD mutations poses challenges to vaccine efficacy
Externí odkaz:
https://doaj.org/article/5d3cc60b97e84872af4f17fef3c28f83
Autor:
Chang-Kyu Heo, Won-Hee Lim, Jihyun Yang, Sumin Son, Sang Jick Kim, Doo-Jin Kim, Haryoung Poo, Eun-Wie Cho
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. Numerous virus-neutralizing antibodies were developed agai
Externí odkaz:
https://doaj.org/article/a14a715b2af8424098a69ca88e937b5a
Autor:
Hai-Min Hwang, Chang-Kyu Heo, Hye Jung Lee, Sang-Seob Kwak, Won-Hee Lim, Jong-Shin Yoo, Dae-Yuel Yu, Kook Jin Lim, Jeong-Yoon Kim, Eun-Wie Cho
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background Tumor-associated (TA) autoantibodies, which are generated by the immune system upon the recognition of abnormal TA antigens, are promising biomarkers for the early detection of tumors. In order to detect autoantibody biomarkers ef
Externí odkaz:
https://doaj.org/article/48bb343635fd472d984c334a592a752a
Publikováno v:
International Journal of Oncology. 61
Tumor‑associated (TA) autoantibodies are considered to be promising biomarkers for the early detection of cancer, prior to the development of clinical symptoms. In the present study, a novel TA autoantibody was detected, which may prove to be usefu
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188075 (2017)
B-cell receptor-associated protein 31 (BAP31) is an endoplasmic reticulum (ER) membrane protein which plays a role as a molecular chaperone for the newly synthesized transmembrane proteins. BAP31 is also an important apoptosis regulator for extrinsic
Externí odkaz:
https://doaj.org/article/b0b6359094f247a594058cd3bbc03e35
Autor:
Jihyun Yang, Vu Minh Phan, Chang-Kyu Heo, Hau Van Nguyen, Won-Hee Lim, Eun-Wie Cho, Haryoung Poo, Tae Seok Seo
Publikováno v:
SSRN Electronic Journal.
Autor:
Eun-Wie Cho
Publikováno v:
BMB Reports, Vol 45, Iss 12, Pp 677-685 (2012)
In the process of tumorigenesis, normal cells are remodeled to cancer cells and protein expression patterns are changed to those of tumor cells. A newly formed tumor microenvironment elicits the immune system and, as a result, a humoral immune respon
Externí odkaz:
https://doaj.org/article/3866552fdb0c4ebdb980963be9fb1273
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 18
International Journal of Molecular Sciences, Vol 21, Iss 6957, p 6957 (2020)
Volume 21
Issue 18
International Journal of Molecular Sciences, Vol 21, Iss 6957, p 6957 (2020)
Studies have shown that cancer stem cells (CSCs) are involved in resistance and metastasis of cancer
thus, therapies targeting CSCs have been proposed. Here, we report that heat shock 70-kDa protein 1-like (HSPA1L) is partly involved in enhancin
thus, therapies targeting CSCs have been proposed. Here, we report that heat shock 70-kDa protein 1-like (HSPA1L) is partly involved in enhancin
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-17 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-17 (2021)
Cancer stem cells (CSCs) are regarded as essential targets to overcome tumor progression and therapeutic resistance; however, practical targeting approaches are limited. Here, we identify testis-specific Y-like protein 5 (TSPYL5) as an upstream regul